Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nripen Singh"'
Publikováno v:
Journal of Pharmaceutical Sciences. 110:3535-3539
The buffering component selection is a key criterion for the formulation development process for biopharmaceuticals. This decision for recombinant adeno-associated virus (rAAV) mediated gene therapies is receiving special attention due to their rise
Autor:
Xuankuo Xu, Nripen Singh, Zheng Jian Li, Steven J. Traylor, Ohnmar Khanal, Abraham M. Lenhoff, Sanchayita Ghose, Chao Huang
Publikováno v:
Journal of Membrane Science. :464-471
Depth filtration is a commonly-used bioprocessing unit operation for harvest clarification that reduces the levels of process- and product-related impurities such as cell debris, host-cell proteins, nucleic acids and protein aggregates. Since depth f
Autor:
Nripen Singh, Caryn L Heldt
Publikováno v:
Current Opinion in Chemical Engineering. 35:100780
Publikováno v:
Biotechnology Progress. 34:1137-1148
This work examines the ultrafiltration behavior of partially retained proteins like lysozyme and completely retained proteins like monoclonal antibodies using single pass tangential flow filtration (SPTFF) modules with different screen channels and m
Autor:
Joon Chong Yee, Nesredin Mussa, Zhijun Tan, Nripen Singh, Anthony J. Cura, Cheng Du, Zheng Jian Li, Ameya Borwankar, Michael C. Borys, Sanchayita Ghose, Yunping Huang, Richard Ludwig
Publikováno v:
mAbs. 10:500-510
During large-scale monoclonal antibody manufacturing, disulfide bond reduction of antibodies, which results in generation of low molecule weight species, is occasionally observed. When this happens, the drug substance does not meet specifications. Ma
Autor:
Nripen Singh, Ameya Borwankar, Zheng Jian Li, Li Tao, Michael Borys, Jay A. A. West, Yunping Huang, Zhijun Tan, Robert Martin, Richard Ludwig, Cheng Du, Sanchayita Ghose
Publikováno v:
Biotechnology and Bioengineering. 115:900-909
Process control for manufacturing biologics is critical for ensuring product quality, safety, and lot to lot consistency of therapeutic proteins. In this study, we investigated the root cause of the pink coloration observed for various in-process poo
Autor:
Deyu Yang, Andrew L. Zydney, Abhiram Arunkumar, Nripen Singh, Sanchayita Ghose, Youngbin Baek, Zheng Jian Li
Publikováno v:
Biotechnology Progress. 33:1555-1560
Diafiltration is used for final formulation of essentially all biotherapeutics. Several studies have demonstrated that buffer/excipient concentrations in the final diafiltered product can be different than that in the diafiltration buffer due to inte
Publikováno v:
Journal of Pharmaceutical Sciences. 106:1978-1986
We describe a noninvasive method developed to make in situ measurements of protein concentration in frozen drug substance. This technique is based on fluorescence from artificially labeled protein and a charge-coupled device camera. Data collected us
Autor:
Andrew L. Zydney, Nripen Singh, Zheng J. Li, Youngbin Baek, Michael C. Borys, Abhiram Arunkumar
Publikováno v:
Biotechnology and Bioengineering. 114:2057-2065
Ultrafiltration (UF) is used for the final concentration and formulation of essentially all antibody-based therapeutics including both monoclonal antibodies (mAbs) and Fc-fusion proteins. The objective of this study was to quantitatively compare the
Publikováno v:
Journal of Membrane Science. 528:171-177
Fc-fusion proteins are an important new class of biotherapeutics; however, there is currently little published data on the behavior of these proteins in downstream processing operations. The objective of this study was to evaluate the ultrafiltration